February 24, 2021
Taisho Pharmaceutical said on February 22 that it has filed an orally disintegrating (OD) film version of its type 2 diabetes treatment Lusefi (luseogliflozin) in Japan, which is currently available in a tablet form. An SGLT2 inhibitor, Lusefi was launched...read more